Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Wafer formulation of rizatriptan delivers fast and effective migraine relief

Sep. 16, 1998

First phase III MS results reported for Novantrone

Sep. 15, 1998

Cerebrus enters into collaborative agreement with Lilly for CEB-1555

Sep. 15, 1998

Scios will copromote SmithKline Beecham's SSRI

Sep. 15, 1998

Pierre Fabre describes pharmacological profile of F-11440 -- new high-efficacy 5-HT1A agonist

Sep. 15, 1998

Potent mGluR1/mGluR5 receptor antagonist presented by Lilly at EFMC symposium

Sep. 15, 1998

SmithKline Beecham research leads to discovery of potent and selective 5-HT7 antagonists

Sep. 15, 1998

F-12682: new 5-HT1B/1D receptor inverse agonist for depression

Sep. 15, 1998

Interneuron receives U.S. patent protection for stroke Rx

Sep. 15, 1998

Capsazepine attenuates inflammation-induced hyperalgesic responses

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...